Last reviewed · How we verify

NCT04738396

Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia

Completed Last updated 21 February 2023
What this trial tests

trial in Cardiac Pacing in 52 participants. Completed in 8 December 2022.

Timeline
29 December 2020
Primary endpoint
6 September 2022
8 December 2022

Quick facts

Lead sponsorMedtronic Cardiac Rhythm and Heart Failure
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date29 December 2020
Primary completion6 September 2022
Estimated completion8 December 2022
Sites4 locations across China

Conditions studied

Sponsor

Medtronic Cardiac Rhythm and Heart Failure — full company profile →

Who can join

Adults 18 to 80, any sex, with Cardiac Pacing or Pacing Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-site, non-randomized, data collection study. The purpose of this study is to investigate the cardiac electrical and mechanical function during LBBAP with different AV intervals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiac Pacing

Currently open trials in the same condition.

Other Medtronic Cardiac Rhythm and Heart Failure trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04738396.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing